Benjamin D Pollock1, Patrick Stuchlik2, Emily W Harville2, Katherine T Mills2, Wan Tang3, Wei Chen2, Lydia A Bazzano2. 1. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA; Department of Epidemiology, Center for Clinical Effectiveness, Baylor Scott & White Health, Dallas, TX, USA; Robbins Institute for Health Policy & Leadership, Baylor University, Waco, TX, USA. Electronic address: pollockben16@gmail.com. 2. Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. 3. Department Global Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Abstract
BACKGROUND AND AIMS: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. METHODS: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). RESULTS: Between the mean ages of 9.6-48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p = .12) and lower BMIs (32.4 kg/m2vs. 34.6 kg/m2; p = .06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p < .0001) and PWV (7.8 m/s vs. 8.2 m/s; p = .03) than the High-High group. For all outcomes, those in the Low-Low group fared best. CONCLUSIONS: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
BACKGROUND AND AIMS: In this analysis, we estimated population-level trajectory groups of life course cardiovascular risk to explore their impact on mid-life atherosclerotic and metabolic outcomes. METHODS: This prospective study followed n = 1269 Bogalusa Heart participants, each with at least 4 study visits from childhood in 1973 through adulthood in 2016. We used discrete mixture modeling to determine trajectories of cardiovascular risk percentiles from childhood to adulthood. Outcomes included mid-life subclinical atherosclerotic measures [(carotid intima-media thickness (cIMT), pulse wave velocity (PWV)], metabolic indicators [(diabetes and body mass index (BMI)], and short physical performance battery (SPPB). RESULTS: Between the mean ages of 9.6-48.3 years, we estimated five distinct trajectory groups of life course cardiovascular risk (High-Low, High-High, Mid-Low, Low-Low, and Low-High). Adult metabolic and vascular outcomes were significantly determined by life course cardiovascular risk trajectory groups (all p < 0.01). Those in the High-Low group had lower risks of diabetes (20% vs. 28%, respectively; p = .12) and lower BMIs (32.4 kg/m2vs. 34.6 kg/m2; p = .06) than those who remained at high risk (High-High) throughout life. However, the High-Low group had better cIMT (0.89 mm vs. 1.05 mm; p < .0001) and PWV (7.8 m/s vs. 8.2 m/s; p = .03) than the High-High group. For all outcomes, those in the Low-Low group fared best. CONCLUSIONS: We found considerable movement between low- and high-relative cardiovascular risk strata over the life course. Children who improved their relative cardiovascular risk over the life course achieved better mid-life atherosclerotic health despite maintaining relatively poor metabolic health through adulthood.
Authors: Juan Pablo Rey-López; Leandro Fornias de Rezende; Thiago Hérick de Sá; Emmanuel Stamatakis Journal: Am J Epidemiol Date: 2015-09-12 Impact factor: 4.897
Authors: Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi Journal: JAMA Date: 2009-04-15 Impact factor: 56.272
Authors: Mark J Pletcher; Eric Vittinghoff; Anusorn Thanataveerat; Kirsten Bibbins-Domingo; Andrew E Moran Journal: PLoS One Date: 2016-05-03 Impact factor: 3.240
Authors: Claire L Leiser; Marissa Taddie; Rachael Hemmert; Rebecca Richards Steed; James A VanDerslice; Kevin Henry; Jacob Ambrose; Brock O'Neil; Ken R Smith; Heidi A Hanson Journal: Cancer Causes Control Date: 2020-04-22 Impact factor: 2.506
Authors: Ileana De Anda-Duran; Camilo Fernandez Alonso; David J Libon; Owen T Carmichael; Vijaya B Kolachalama; Shakira F Suglia; Rhoda Au; Lydia A Bazzano Journal: Neurology Date: 2022-02-28 Impact factor: 11.800
Authors: Jessica R McCann; Nathan A Bihlmeyer; Kimberly Roche; Cameron Catherine; Jayanth Jawahar; Lydia Coulter Kwee; Noelle E Younge; Justin Silverman; Olga Ilkayeva; Charles Sarria; Alexandra Zizzi; Janet Wootton; Lisa Poppe; Paul Anderson; Michelle Arlotto; Zhengzheng Wei; Joshua A Granek; Raphael H Valdivia; Lawrence A David; Holly K Dressman; Christopher B Newgard; Svati H Shah; Patrick C Seed; John F Rawls; Sarah C Armstrong Journal: Obesity (Silver Spring) Date: 2021-03 Impact factor: 5.002
Authors: Baibing Mi; Chenlu Wu; Xiangyu Gao; Wentao Wu; Jiaoyang Du; Yaling Zhao; Duolao Wang; Shaonong Dang; Hong Yan Journal: BMJ Open Diabetes Res Care Date: 2020-07
Authors: Sarah C Armstrong; McAllister Windom; Nathan A Bihlmeyer; Jennifer S Li; Svati H Shah; Mary Story; Nancy Zucker; William E Kraus; Neha Pagidipati; Eric Peterson; Charlene Wong; Manuela Wiedemeier; Lauren Sibley; Samuel I Berchuck; Peter Merrill; Alexandra Zizzi; Charles Sarria; Holly K Dressman; John F Rawls; Asheley C Skinner Journal: BMC Pediatr Date: 2020-06-26 Impact factor: 2.125
Authors: Jiali Lv; Bingbing Fan; Mengke Wei; Guangshuai Zhou; Alim Dayimu; Zhenyu Wu; Chang Su; Tao Zhang Journal: BMJ Open Diabetes Res Care Date: 2020-04
Authors: Chen Botvin Moshe; Salo Haratz; Ramit Ravona-Springer; Anthony Heymann; Lin Hung-Mo; Michal Schnaider Beeri; David Tanne Journal: Cardiovasc Diabetol Date: 2020-09-15 Impact factor: 9.951
Authors: Holly C Gooding; Samuel S Gidding; Andrew E Moran; Nicole Redmond; Norrina B Allen; Fida Bacha; Trudy L Burns; Janet M Catov; Michael A Grandner; Kathleen Mullan Harris; Heather M Johnson; Michaela Kiernan; Tené T Lewis; Karen A Matthews; Maureen Monaghan; Jennifer G Robinson; Deborah Tate; Kirsten Bibbins-Domingo; Bonnie Spring Journal: J Am Heart Assoc Date: 2020-09-30 Impact factor: 5.501